# Herantis Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/herantis-pharma

- Industry: Biotechnology
- Headquarters: Helsinki, Finland
- Website: www.hermopharma.com
- Latest round: Series A (Apr 25, 2012)
- Investors on record: 2

## About

Based in Helsinki, Finland, and founded in 2008, Hermo Pharma Oy Ltd operates as a biopharmaceutical company that offers therapeutic solutions for untreatable medical needs. The company was founded by Mart Saarma, Eero Castrén, Heikki Rauvala, and Henri Huttunen. As of 2016, Hermo Pharma Oy Ltd merged with Laurantis Pharma to form Herantis Pharma. As of 2011, the company is led by its CEO Juhani Lahdenperä.

The firm develops treatments for neurological diseases. It develops disease-modifying treatments for amblyopia (lazy eye), Parkinson’s disease, and Alzheimer’s disease. The products offered by the firm improve symptoms of the disease and prevent further disease progression.

## Funding rounds

- Series A, Apr 25, 2012 — Finnvera, Helsinki University Funds

## Investors

- Finnvera (https://capitalatlas.ai/funds/finnvera) — Series A
- Helsinki University Funds — Series A